The latest closing stock price for Virax Biolabs Group as of November 20, 2024 is 1.88.
An investor who bought $1,000 worth of Virax Biolabs Group stock at the IPO in 2022 would have $-897 today, roughly -1 times their original investment - a -67.86% compound annual growth rate over 2 years.
The all-time high Virax Biolabs Group stock closing price was 20.80 on July 28, 2022.
The Virax Biolabs Group 52-week high stock price is 9.00, which is 378.7% above the current share price.
The Virax Biolabs Group 52-week low stock price is 0.13, which is 93.1% below the current share price.
The average Virax Biolabs Group stock price for the last 52 weeks is 1.42.
An investor who bought $1,000 worth of Virax Biolabs Group stock at the IPO in 2022 would have $-897 today, roughly -1 times their original investment - a -67.86% compound annual growth rate over 2 years.
The all-time high Virax Biolabs Group stock closing price was 20.80 on July 28, 2022.
The Virax Biolabs Group 52-week high stock price is 9.00, which is 378.7% above the current share price.
The Virax Biolabs Group 52-week low stock price is 0.13, which is 93.1% below the current share price.
The average Virax Biolabs Group stock price for the last 52 weeks is 1.42.